Meeting of experts and practical vision of cardiovascular risk
Patients with a cardiovascular (CV) risk factor, especially hypertensive patients, have had a worse prognosis in relation to SARS-CoV2 infection. The reasons are the reason for multiple studies globally. The experience associated with the pandemic does not go beyond a few months; However, the knowledge obtained thanks to the efforts of healthcare professionals and the advantages of the available technology have allowed the understanding of the mechanisms related to CV risk factors and the development of pathology associated with infection to be growing and to be able to share across the board.
The objective of these modules is precisely to share knowledge and experience on CV risk factors and learning related to the evolution of the SARS-CoV2 pandemic, with experts with great communication skills through the use of the technology to achieve greater efficiency.
The accent will be placed on the anticipation of future similar episodes and on the lessons we must learn to optimize the management of this high-risk population.
Enrollment class periods:
- 1st term: from 1/4/2021 to 6/27/2021
- 2nd term: from 1/7/2021 to 26/9/2021
- 3rd term: from 10/1/2021 to 12/26/2021
- 4th term: from 10/1/2022 to 27/3/2022
Course sponsored by:
The modules that make up the course are:
M1. Learning from the past. How to interpret global data based on cardiovascular risk?
M2. Impact of cardiovascular diseases in the 2020 pandemic
M3. Should we rethink the role of renin-angiotensin system inhibitors in the management of hypertensive patients in the short term?
M4. Ischemic heart disease and heart failure and its relationship with SARS-CoV-2. How to prevent them?
M5. Prognostic factors in patients who have overcome COVID19 infection. What variables to focus on in the coming months?
M6. Dyslipidemia, statins and COVID. Continuous learning
M7. Thromboembolic disease in the COVID 19 patient. Example of the need for specialized follow-up after a serious illness
M8. Admission of a hypertensive patient with CRP + after the 1st wave. What to do?
M9. How to approach the therapeutic strategy of the patient with vascular risk based on experience
M10. New challenges for the AHT and Vascular Risk Units. What have we learned?
VIDEOMANUAL DE REGISTRO:
Si ya te Matriculaste
ACCEDE al CAMPUS


Management
Dr. José Antonio García Donaire
Facultativo Especialista de Área en la Unidad de HipertensiónH. Clínico San Carlos, Madrid
Dra. Mónica Domenech
Servicio de Medicina InternaHospital Clínic de Barcelona
Nº de colegiada 32774
Colegio Oficial de Médicos de Barcelona
Staff
Dra. María Abad
Especialista de Medicina Interna en Unidad de HTA y Riesgo VascularHospital Clínico San Carlos, Madrid
Dr. José Abellán
Especialista en Medicina Interna y Catedrático de Riesgo CardiovascularUniversidad Católica de Murcia
Dr. Pedro Armario
Jefe Servicio Área Atención Integrada Riesgo VascularConsorci Sanitari Integral. Hospital Moisès Broggi
Dr. Carlos Brotons
Médico de familiaEquipo de Atención Primaria Sardenya, Barcelona
Dr. Antonio Coca
Unidad de Hipertensión y Riesgo Vascular del Servicio de Medicina InternaHospital Clínic de Barcelona
Dr. Raimundo de Andrés Cañas
Jefe del Servicio de Medicina InternaHospital Universitario Fundación Jiménez Díaz
Dr. Alejandro de la Sierra
Jefe del Servicio de Medicina Interna y Director de DocenciaHospital Universitario Mutua Terrassa
Dr. José María Fernández Rodríguez
Adjunto en el Servicio de Medicina InternaHospital de Cangas de Narcea
Dr. Juan González del Castillo
Jefe de Unidad del Servicio de UrgenciasHospital Universitario Clínico San Carlos, Madrid
Dr. Carlos Guijarro
Especialista en Medicina InternaHospital Universitario Fundación Alcorcón
Dra. Nieves Martell
Unidad de Hipertensión y Factores de Riesgo. Medicina InternaHospital Clínico San Carlos, Madrid
Dr. Manuel Méndez
Especialista en Medicina InternaHospital Clínico San Carlos, Madrid
Dr. Enrique Morales
Servicio de NefrologíaHospital Universitario 12 de Octubre, Madrid
Dr. Vicente Pallarés
Medico de Familia. Responsable del Sistema de Gestión de Seguridad del Paciente, Unidad de Vigilancia de la SaludUnión de Mutuas, Castellón
Dr. Leopoldo Pérez de Isla
Jefe de la Unidad de Imagen CardiovascularHospital Clínico San Carlos, Madrid
Dr. Joan Carles Reverter
Jefe de Servicio del Servicio de Hemoterapia y HemostasiaHospital Clínic de Barcelona
Dr. Daniel Rey
Medico de FamíliaCentro de Saude A Estrada, Pontevedra
Dr. Enrique Rodilla
Responsable de la Unidad de HTA y Riesgo Vascular, Medicina InternaHospital de Sagunto, Valencia
Dra. Esther Rubio
Medico adjunto especialista en nefrología. Responsable del área de HTA y RCVHospital Universitario Puerta de Hierro, Majadahonda
Dr. Julián Segura
Médico Especialista en NefrologíaHospital Universitario 12 de Octubre, Madrid
Dr. Javier Sobrino
Jefe de MedicinaFundació Hospital de l’Esperit Sant, Santa Coloma de Gramenet, Barcelona
Dr. David Vivas
Facultativo Especialista Área CardiologíaHospital Clínico San Carlos, Madrid